PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease	Active, not recruiting	Phase 3	2025-07-16		NCT04907370

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanghai Junshi Bioscience Co., Ltd.	42
Sun Yat-sen University	606

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Cancer Hospital	Beijing	China	55
Cancer Hospital of Guangxi Medical University	Nanning	China	5
Cancer Hospital of Guizhou Medical University	Guiyang	China	4
Chongqing Cancer Hospital	Chongqing	China	6
First People's Hospital of Foshan	Foshan	China	3
Hubei Province Cancer Hosiptal	Wuhan	China	3
Jiangxi Province Cancer Hospital	Nanchang	China	1
Panyu central hospital	Guangzhou	China	1
Tongji Hospital Affiliated with Tongji Medical College of Huazhong University of Science and Technology	Wuhan	China	3
Union Hospital Affiliated with Tongji Medical College of Huazhong University of Science and Technology	Wuhan	China	4
Xiangya Hospital Central South University	Changsha	China	27
Zhejiang Province Cancer Hospital	Hangzhou	China	2